Signaling through the Ras-mitogen-activated protein kinase and Akt pathways as a result of EGFR amplification and mutation and deletion of PTEN, respectively, may result in tumor growth even in the presence of PDGFR inhibition. The gene discussed is PTEN; the disease is neoplasm.